XML 76 R51.htm IDEA: XBRL DOCUMENT v3.20.1
Financial Instruments and Fair Value Measurements (Narrative) (Details) - USD ($)
$ / shares in Units, $ in Millions
3 Months Ended 12 Months Ended
Feb. 25, 2020
Mar. 27, 2020
Dec. 27, 2019
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis      
Contingent Consideration, Liability, Current   $ 62.1  
Contingent Consideration, Liability, Noncurrent   $ 6.7  
Senior Notes | 5.75% Senior Notes      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis      
Debt Instrument, Interest Rate, Stated Percentage   5.75%  
Senior Notes | 4.88% Senior Notes      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis      
Debt Instrument, Interest Rate, Stated Percentage   4.875%  
Senior Notes | 10.00% Second Lien Senior Notes      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis      
Debt Instrument, Interest Rate, Stated Percentage   10.00%  
Level 3 | Other current and non-current assets      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis      
Cash surrender value of life insurance   $ 51.0 $ 51.1
Level 3 | Recurring | Questcor Pharmaceuticals, Inc.      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis      
Fair value of contingent liability   24.8 24.5
Level 3 | StrataGraft [Member] | Recurring | Stratatech      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis      
Fair value of contingent liability   31.4 29.0
Level 3 | MNK-6105 [Member] | Recurring | Ocera [Member]      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis      
Fair value of contingent consideration   $ 12.6 15.8
Level 2 | Debentures | 8.00% Debenture      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis      
Debt Instrument, Interest Rate, Stated Percentage   8.00%  
Level 2 | Debentures | 9.50% Debenture      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis      
Debt Instrument, Interest Rate, Stated Percentage   9.50%  
Level 1 | Senior Notes | 4.75% Senior Notes      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis      
Debt Instrument, Interest Rate, Stated Percentage   4.75%  
Level 1 | Senior Notes | 5.75% Senior Notes      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis      
Debt Instrument, Interest Rate, Stated Percentage   5.75%  
Level 1 | Senior Notes | 4.88% Senior Notes      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis      
Debt Instrument, Interest Rate, Stated Percentage   4.875%  
Level 1 | Senior Notes | 5.50% Senior Notes      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis      
Debt Instrument, Interest Rate, Stated Percentage   5.50%  
Level 1 | Senior Notes | 10.00% Second Lien Senior Notes      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis      
Debt Instrument, Interest Rate, Stated Percentage   10.00%  
Level 1 | Unsecured Debt | 5.625% Senior Notes      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis      
Debt Instrument, Interest Rate, Stated Percentage   5.625%  
Nuclear Imaging | Level 3      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis      
Contingent Consideration, Equity Certificates   $ 29.8 18.9
Indemnification Agreement | Mallinckrodt Baker | Level 1 | Other current and non-current assets      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis      
Restricted Cash and Cash Equivalents   41.2 31.7
Contingent Liabilities | Level 3 | Recurring      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis      
Fair value adjustment   0.8  
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value   $ 68.8 $ 69.3
Opioid Claimant Trust [Member]      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis      
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate   64.10% 54.40%
Warrant, Exercise Price $ 3.15    
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate   0.60% 1.80%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate   0.00% 0.00%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term   7 years 7 months 6 days 7 years 7 months 6 days
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value   $ 2.23 $ 3.45
Opioid Claimant Trust [Member] | Maximum      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis      
Acquisition of Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners, Quarterly Limit 5.00%    
Other Ownership Interest [Member] | Opioid Claimant Trust [Member] | Maximum      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis      
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners 19.99%